Pilot Study Evaluation of 2 Artificial Tears. Evaluation of TBUT, Tear Meniscus Height and Tear Thickness
This study has been completed.
Sponsor:
Innovative Medical
Information provided by:
Innovative Medical
ClinicalTrials.gov Identifier:
NCT00469521
First received: May 2, 2007
Last updated: September 5, 2007
Last verified: September 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine baseline tear thickness and improvement immediately post installation of two artificial tear solutions:(9582X) and Allergan Refresh Tears.
| Condition | Intervention | Phase |
|---|---|---|
|
Tear Film Thickness |
Drug: Refresh Tears, 9582X |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Intervention Model: Parallel Assignment Masking: Open Label |
Resource links provided by NLM:
Further study details as provided by Innovative Medical:
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
Criteria
Inclusion Criteria:
- Normal, healthy volunteers 18 years or older
- Males or females
- Any race or ethnic background
Exclusion Criteria:
- Corneal refractive surgery within 6 months of this study.
- Contact lens use on day of examination.
- Corneal ectasia
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00469521
Locations
| United States, South Carolina | |
| Magill Research Center Institute MUSC | |
| Charleston, South Carolina, United States, 29425 | |
Sponsors and Collaborators
Innovative Medical
Investigators
| Principal Investigator: | Helga Sandoval, MS, MD | Magill Research Center Institute MUSC |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00469521 History of Changes |
| Other Study ID Numbers: | 5304 |
| Study First Received: | May 2, 2007 |
| Last Updated: | September 5, 2007 |
| Health Authority: | United States:Institution Review Board |
Additional relevant MeSH terms:
|
Carboxymethylcellulose Sodium Laxatives Gastrointestinal Agents Therapeutic Uses Pharmacologic Actions |
ClinicalTrials.gov processed this record on June 18, 2013